Ajanta Pharma gets USFDA approval for Zolmitriptan Tablets

24 May 2016 Evaluate

Ajanta Pharma has received final approval of Zolmitriptan tablets (2.5mg, 5mg) from the U.S. Food and Drug Administration (FDA). Zolmitriptan is used in the acute treatment of migraine and is an equivalent generic version of Zomig1.

Zolmitriptan Tablets is part of an ever-growing portfolio of products that Ajanta has developed for the U.S. market. To date, the United States Food & Drug Administration (U.S.FDA) has granted Ajanta Pharma 9 ANDA final approvals and 2 tentative approvals. Additional 15 ANDAs are under review with the FDA.

Ajanta Pharma is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. Over 6,000 employees are engaged in developing, manufacturing and marketing of quality finished dosages across 30+ countries.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×